Long-Term Followup of Dextranomer/Hyaluronic Acid Injection for Vesicoureteral Reflux: Late Failure Warrants Continued Followup
Authors:
- 1 April 2009
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 181 (4) , 1869-1875
Abstract
Dextranomer/hyaluronic acid injection of ureteral orifices is a popular option in the treatment of vesicoureteral reflux, with success rates ranging from 69% to 89%. We found only 1 study that followed patients beyond the initial postoperative voiding cystourethrogram, which describes a 96% success rate at 2 to 5 years but defines success as "nondilating" reflux. We examined our dextranomer/hyaluronic acid series to evaluate the long-term (1-year) outcome in children who had resolution of reflux on initial postoperative voiding cystourethrography. We retrospectively reviewed our dextranomer/hyaluronic acid experience from February of 2002 to December of 2005. We determined initial success on early (6 to 12-week) postoperative voiding cystourethrogram. We then evaluated long-term success by obtaining a voiding cystourethrogram at 1 year postoperatively in patients who were initially cured of reflux. In addition, success rates between the first and second halves of our experience were evaluated to account for surgeon experience and modification of technique. Our total success rate at initial voiding cystourethrogram was 73% (246 of 337 total ureters). The success rate in the first half of our experience was 65.9% (112 of 170 ureters) and in the second half was 80.2% (134 of 167). A total of 150 ureteral units with initial successful dextranomer/hyaluronic acid treatment were evaluated at 1 year by voiding cystourethrogram. Of these ureters 111 had continued resolution of vesicoureteral reflux, for a long-term success rate of 74%. Including initial postoperative failures, the complete 1-year total success rate was 46.1% (111 of 241 ureters). Although the reflux resolution rates at initial postoperative voiding cystourethrogram approach those of open surgery, there is a significant failure rate at 1 year, which warrants long-term followup.Keywords
This publication has 16 references indexed in Scilit:
- Multivariate Comparison of the Efficacy of Intraureteral Versus Subtrigonal Techniques of Dextranomer/Hyaluronic Acid InjectionJournal of Urology, 2007
- Multivariate Analysis of Factors Predicting Success With Dextranomer/Hyaluronic Acid Injection for Vesicoureteral RefluxJournal of Urology, 2007
- The Evolution of Vesicoureteral Reflux Management in the Era of Dextranomer/Hyaluronic Acid Copolymer: A Pediatric Health Information System Database StudyJournal of Urology, 2006
- Endoscopic Therapy for Vesicoureteral Reflux: A Meta-Analysis. I. Reflux Resolution and Urinary Tract InfectionJournal of Urology, 2006
- THE MODIFIED STING PROCEDURE TO CORRECT VESICOURETERAL REFLUX: IMPROVED RESULTS WITH SUBMUCOSAL IMPLANTATION WITHIN THE INTRAMURAL URETERJournal of Urology, 2004
- Antibiotics and surgery for vesicoureteric reflux: a meta-analysis of randomised controlled trialsArchives of Disease in Childhood, 2003
- LONG-TERM FOLLOWUP OF CHILDREN TREATED WITH DEXTRANOMER/HYALURONIC ACID COPOLYMER FOR VESICOURETERAL REFLUXJournal of Urology, 2001
- Pediatric Vesicoureteral Reflux Guidelines Panel Summary Report on the Management of Primary Vesicoureteral Reflux in ChildrenJournal of Urology, 1997
- Relationship among vesicoureteral reflux, P-fimbriated Escherichia coli, and acute pyelonephritis in children with febrile urinary tract infectionThe Journal of Pediatrics, 1991
- Properties of Escherichia coli in Patients with Renal ScarringThe Journal of Infectious Diseases, 1989